Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers
- 1 February 2021
- journal article
- Published by Wiley
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (7P20RR017662‐07, R56 HL131547, U24 DK097154)
- U.S. Department of Agriculture (2032‐51530‐022‐00D, 2032‐51530‐022‐25D)
This publication has 52 references indexed in Scilit:
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseCochrane Database of Systematic Reviews, 2018
- Effects of n−3 Fatty Acid Supplements in Diabetes MellitusNew England Journal of Medicine, 2018
- An overview of the biologic effects of omega-6 oxylipins in humansProstaglandins, Leukotrienes & Essential Fatty Acids, 2018
- Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acidsProstaglandins, Leukotrienes & Essential Fatty Acids, 2017
- Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitisProstaglandins & Other Lipid Mediators, 2016
- Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipinsProstaglandins & Other Lipid Mediators, 2014
- Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFAProstaglandins & Other Lipid Mediators, 2014
- Impact of circulating esterified eicosanoids and other oxylipins on endothelial functionCurrent Atherosclerosis Reports, 2009
- Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteinsProstaglandins, Leukotrienes & Essential Fatty Acids, 2008